DURATA THERAPEUTICS
Durata was created by a five-member venture capital syndicate to pursue late-stage clinical development of novel antibiotic programs. The acquisition was funded through a stock purchase by New Leaf Venture Partners, LLC, Domain Associates, LLC, Aisling Capital, Sofinnova Ventures Inc. and Canaan Partners. Durata is focused on Vicuron’s antibiotic drug candidate, dalbavancin. Its product portfolio also includes two preclinical antibiotic programs while Pfizer will retain the marketed anti-fungal agent, EraxisTM, which was formerly owned by Vicuron.
DURATA THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2009-01-01
Address:
Branford, Connecticut, United States
Country:
United States
Website Url:
http://www.duratatherapeutics.com
Total Employee:
51+
Status:
Closed
Contact:
312-219-7000
Email Addresses:
[email protected]
Total Funding:
70 M USD
Technology used in webpage:
SPF Amazon Microsoft Azure DNS Amazon Virginia Region ASP.NET Ajax Amazon Sydney Region Cisco Ironport Cloud MarkMonitor DNS Xand
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2009-12-21 | Vicuron Pharmaceuticals | Vicuron Pharmaceuticals acquired by Durata Therapeutics | N/A |
Investors List
PDL Biopharma
PDL Biopharma investment in Post-IPO Equity - Durata Therapeutics
Official Site Inspections
http://www.duratatherapeutics.com
Unable to get host informations!!!
More informations about "Durata Therapeutics"
Durata Therapeutics - Crunchbase Company Profile & Funding
Durata was created by a five-member venture capital syndicate to pursue late-stage clinical development of novel antibiotic programs. The acquisition was funded through a stock …See details»
Durata Therapeutics Company Profile | Management and
Durata Therapeutics Profile and History. Durata Therapeutics is a pharmaceutical company focused on the development and commercialization of new therapeutics for patients with …See details»
Durata Therapeutics - Wikipedia
Durata Therapeutics was a clinical development stage company in the pharmaceutical industry which focused on the treatment of infections. On November 17, 2014, the company was acquired by Actavis (now Allergan) for $675 million. See details»
Durata Therapeutics Company Profile 2024: Valuation, Investors ...
Durata Therapeutics General Information Description. Developer of pharmaceutical treatments for infectious disease and acute illnesses. The company develops and commercializes Dalvance, …See details»
Durata Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Durata Therapeutics, Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Company Information - RocketReach
Durata Therapeutics Inc. established in 2009, is a clinical development stage biopharmaceutical company addressing the growing need for new therapeutics to treat infectious diseases. …See details»
Durata Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Durata Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, 9 news, and 5 literature, Drug:Dalbavancin ...See details»
Durata Therapeutics Overview | SignalHire Company Profile
Durata Therapeutics is a public company that has been in the industry for 13 years. The company currently specializes in the Pharmaceuticals area. ... Organization Website: …See details»
Durata Therapeutics - Ownership and Business Overview - Mergr
Oct 6, 2014 Durata Therapeutics, Inc. is a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute …See details»
Durata Therapeutics - VentureRadar
Durata is a biopharmaceutical company pursuing late-stage clinical development of novel antibiotic programs. ... Find out more about Durata Therapeutics, Biotechnology and Infectious …See details»
Durata - VentureRadar
Durata Therapeutics USA n/a Durata is a biopharmaceutical company pursuing late-stage clinical development of novel antibiotic programs. Better On Call Unknown n/a Better On Call …See details»
Durata Therapeutics - Products, Competitors, Financials, …
Durata Therapeutics is a pharmaceutical company focused on the development and commercialization of therapeutics for patients with infectious diseases and acute illnesses. …See details»
Durata Therapeutics - Contacts, Employees, Board Members
Organization. Durata Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Highlights. Employee Profiles 4. Number of Board Member and …See details»
Durata Therapeutics, Inc.:Company Profile & Technical Research ...
Durata Therapeutics is a company that provides Dalbavancin, Medicine, Health care and more. Durata Therapeutics is headquartered in United States Connecticut. Durata Therapeutics was …See details»
Durata Therapeutics, Inc.
Durata Therapeutics is a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute …See details»
Durata Therapeutics - EquityNet
Durata was created by a five-member venture capital syndicate to pursue late-stage clinical development of novel antibiotic programs. The acquisition was funded through a stock …See details»
Durata Therapeutics Relocating Corporate Headquarters to Chicago
Nov 14, 2012 Durata Therapeutics, founded in Morristown, N.J., is focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute …See details»
Durata Therapeutics U.S. Limited - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Durata Therapeutics U.S. Limited of Chicago, IL. Get the latest business insights from Dun & Bradstreet.See details»
Working at Durata Therapeutics: 7 Reviews - Indeed
Reviews from Durata Therapeutics employees about Durata Therapeutics culture, salaries, benefits, work-life balance, management, job security, and more.See details»